RSS Feeds
Search

Companies

Companies

Displaying 1..1 of 1 - per page
Order by
Profiled on pharmalicensing.com Amarin Technologies S.A.
Amarin is engaged in the development of innovative pharmaceutical products using its proprietary topical and transdermal drug delivery technologies and know-how. More
Displaying 1..1 of 1 - per page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Prostate Cancer Drug Discoveries: What the Future Holds
Nov 2009 - 160 pages - $2,265
Nonmelanomatous Skin Cancer - Pipeline Review, Q4 2010
Dec 2010 - 26 pages - $500
US Oncology, Inc. - SWOT Analysis
Nov 2010 - 26 pages - $125
Nonmelanomatous Skin Cancer - Pipeline Review, H2 2011
Aug 2011 - 42 pages - $500
Nonmelanomatous Skin Cancer - Pipeline Review, Q2 2011
Apr 2011 - 42 pages - $500
Innovations in the Delivery of Cancer Therapies
Jan 2011 - 231 pages - $3,835
Skin Cancer and Melanoma Therapy Area Pipeline Report
Nov 2010 - 639 pages - $1,495
Successes and Failures for Avastin (Bevacizumab) mean Mixed News for the Blockbuster Drug in the Oncology Therapeutics Market
May 2011 - 7 pages - $500
US Oncology, Inc.: SWOT Analysis & Company Profile
Dec 2010 - 19 pages - $99
Systemic Sclerosis (Scleroderma) - Pipeline Review, Q4 2010
Dec 2010 - 40 pages - $500
More Related Market Research Reports >>>

Your selection

Industry sector
Drug delivery del
Systemic del
Therapeutic target
Oncology del
Skin cancer del

Browse By

Industry sector
Aerosol
Cream
Dressing
Inhaler
Transdermal system
Therapeutic target
Basal cell carcinoma
Melanoma
Squamous cell carcinoma
Geographic location
Africa
Asia
Australia/New Zealand
Central America
Europe
Near & Far East
North America
South America

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us